Pluristem Therapeutics Increases Testing of PLX Cells For Radiation (PSTI)

Pluristem Therapeutics PSTI increases its testing of PLX Cells for the treatment of radiation exposure.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDABiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!